Adverum Biotechnologies Statistics

Total Valuation

LON:0HA3 has a market cap or net worth of GBP 32.78 million. The enterprise value is 40.15 million.

Market Cap	32.78M
Enterprise Value	40.15M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.89M
Shares Outstanding	n/a
Shares Change (YoY)	+78.69%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.36
PB Ratio	1.60
P/TBV Ratio	1.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.34
EV / Sales	55.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.46

Financial Position

The company has a current ratio of 3.57, with a Debt / Equity ratio of 3.53.

Current Ratio	3.57
Quick Ratio	3.31
Debt / Equity	3.53
Debt / EBITDA	n/a
Debt / FCF	-0.83
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -144.51% and return on invested capital (ROIC) is -52.53%.

Return on Equity (ROE)	-144.51%
Return on Assets (ROA)	-48.76%
Return on Invested Capital (ROIC)	-52.53%
Return on Capital Employed (ROCE)	-140.53%
Revenue Per Employee	4,993
Profits Per Employee	-753,012
Employee Count	155
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-66.73%
50-Day Moving Average	2.63
200-Day Moving Average	4.91
Relative Strength Index (RSI)	40.09
Average Volume (20 Days)	5,715

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.70

Income Statement

In the last 12 months, LON:0HA3 had revenue of GBP 773,990 and -116.72 million in losses. Loss per share was -5.59.

Revenue	773,990
Gross Profit	-69.18M
Operating Income	-122.43M
Pretax Income	-116.72M
Net Income	-116.72M
EBITDA	-119.85M
EBIT	-122.43M
Loss Per Share	-5.59

Full Income Statement

Balance Sheet

The company has 64.31 million in cash and 72.12 million in debt, giving a net cash position of -7.81 million.

Cash & Cash Equivalents	64.31M
Total Debt	72.12M
Net Cash	-7.81M
Net Cash Per Share	n/a
Equity (Book Value)	20.45M
Book Value Per Share	0.98
Working Capital	49.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -86.68 million and capital expenditures -400,927, giving a free cash flow of -87.08 million.

Operating Cash Flow	-86.68M
Capital Expenditures	-400,927
Free Cash Flow	-87.08M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-15,818.10%
Pretax Margin	-15,079.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0HA3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.69%
Shareholder Yield	n/a
Earnings Yield	-356.02%
FCF Yield	-265.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 21, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Mar 21, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

LON:0HA3 has an Altman Z-Score of -13.77 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.77
Piotroski F-Score	1